SMT202100643T1 - Derivati del benzossaborolo per il trattamento delle infezioni batteriche - Google Patents

Derivati del benzossaborolo per il trattamento delle infezioni batteriche

Info

Publication number: SMT202100643T1
Authority: SM; San Marino
Prior art keywords: bacterial infections; treating bacterial; benzoxaborole derivatives; benzoxaborole; derivatives
Prior art date: 2010-09-07

Application number

SM20210643T

Other languages

English (en)

Inventor

Ding Zhou

Xianfeng Li

Vincent S Hernandez

Charles Ding

Jacob J Plattner

Michael Richard Kevin Alley

Fernando Rock

Suoming Zhang

Eric Easom

Original Assignee

Anacor Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-09-07

Filing date

2011-09-07

Publication date

2022-01-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT202100643(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-09-07 Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc

2022-01-10 Publication of SMT202100643T1 publication Critical patent/SMT202100643T1/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SM20210643T 2010-09-07 2011-09-07 Derivati del benzossaborolo per il trattamento delle infezioni batteriche SMT202100643T1 (it)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38059610P	2010-09-07	2010-09-07
EP17176654.6A EP3251678B1 (en)	2010-09-07	2011-09-07	Benzoxaborole derivatives for treating bacterial infections

Publications (1)

Publication Number	Publication Date
SMT202100643T1 true SMT202100643T1 (it)	2022-01-10

Family

ID=44653589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SM20210643T SMT202100643T1 (it)	2010-09-07	2011-09-07	Derivati del benzossaborolo per il trattamento delle infezioni batteriche

Country Status (25)

Country	Link
US (4)	US8703742B2 (it)
EP (2)	EP3251678B1 (it)
JP (4)	JP5952280B2 (it)
KR (2)	KR102152901B1 (it)
CN (2)	CN103140228A (it)
AU (1)	AU2011299243C1 (it)
BR (1)	BR112013005426B1 (it)
CA (1)	CA2810021C (it)
CY (1)	CY1124728T1 (it)
DK (2)	DK2613788T3 (it)
EA (2)	EA028743B1 (it)
ES (2)	ES2635333T3 (it)
HR (1)	HRP20211762T1 (it)
HU (1)	HUE059033T2 (it)
IL (2)	IL225000A (it)
LT (1)	LT3251678T (it)
MX (1)	MX338209B (it)
PL (1)	PL3251678T3 (it)
PT (1)	PT3251678T (it)
RS (1)	RS62548B1 (it)
SG (2)	SG187969A1 (it)
SI (1)	SI3251678T1 (it)
SM (1)	SMT202100643T1 (it)
WO (1)	WO2012033858A2 (it)
ZA (1)	ZA201301598B (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106008583A (zh)	2005-12-30	2016-10-12	安纳考尔医药公司	含硼的小分子
US9440994B2 (en) *	2009-08-14	2016-09-13	Anacor Pharmaceuticals, Inc.	Boron containing small molecules as antiprotozoal agents
WO2011094450A1 (en)	2010-01-27	2011-08-04	Anacor Pharmaceuticals, Inc	Boron-containing small molecules
HRP20211762T1 (hr) *	2010-09-07	2022-02-18	Anacor Pharmaceuticals, Inc.	Derivati benzoksaborola za liječenje bakterijskih infekcija
KR20140114380A (ko)	2011-12-22	2014-09-26	미큐알엑스 파마슈티칼스, 인크.	항미생물 요법용 트리시클릭 붕소 화합물
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
UY35287A (es)	2013-01-30	2014-08-29	Dow Agrosciences Llc	Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas.
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
AP2015008638A0 (en)	2013-02-01	2015-08-31	Anacor Pharmaceuticals Inc	Boron-containing small molecules as antiprotozoal agents
KR101636431B1 (ko)	2013-07-30	2016-07-05	동아에스티 주식회사	트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도
EP3030519B1 (en)	2013-08-09	2022-01-05	Glaxosmithkline Intellectual Property (No. 2) Limited	Tricyclic benzoxaborole compounds and uses thereof
EA038093B1 (ru) *	2013-12-20	2021-07-05	Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед	Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли
EP3164404B1 (en) *	2014-07-01	2019-04-03	Daiichi Sankyo Company, Limited	Tricyclic benzoxaboroles as antibacterial agents
MA41494B1 (fr)	2015-02-12	2020-10-28	Glaxosmithkline Ip No 2 Ltd	Composés benzoxaborole substitués en position 4 et utilisations associées
EP3426029B1 (en)	2016-03-07	2023-08-30	AgroFresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en)	2017-03-01	2021-03-03	Anacor Pharmaceuticals, Inc.	NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
CA3120976A1 (en)	2017-11-30	2019-06-06	Boragen, Inc.	Benzoxaborole compounds and formulations thereof
CN108727176B (zh) *	2018-07-26	2021-05-18	荆楚理工学院	一种制备5-卤-2,3-二羟基苯甲醛的方法
AU2019325436B2 (en)	2018-08-18	2023-10-26	5Metis, Inc.	Solid forms of substituted benzoxaborole and compositions thereof
WO2021021932A1 (en) *	2019-07-30	2021-02-04	Boragen, Inc.	Flow reaction process for manufacture of boron-containing agrochemicals
CN110664756B (zh) *	2019-10-09	2020-11-17	吉林大学	一种小儿外伤喷雾剂及其制备方法
US20230340530A1 (en)	2020-08-31	2023-10-26	Pfizer Inc.	Methods of Protecting RNA
EP4384527A4 (en) *	2022-06-23	2025-09-03	Micurx Pharmaceuticals Inc	PRODRUGS OF BORON COMPOUNDS AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS
JP2025520237A (ja)	2022-06-23	2025-07-03	ミクウルクファーマシューティカルズ，インコーポレイテッド	ホウ素化合物を用いて非結核性マイコバクテリア感染症を治療する方法及びその用途、並びに同じ疾患を治療するための医薬組成物
CN115572218B (zh) *	2022-08-29	2024-04-16	江阴勒森生物科技有限公司	一种2-溴-3-羟基苯甲醛及其相关化学发光底物中间体的制备方法

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en)	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
US3686398A (en)	1970-07-20	1972-08-22	Chevron Res	10,9-boroxarophenanthrene as fungicides
GB1396904A (en)	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US4602011A (en)	1975-10-24	1986-07-22	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4766113A (en)	1975-10-24	1988-08-23	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4716035A (en)	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis
US5962498A (en)	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en)	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
US4919934A (en)	1989-03-02	1990-04-24	Richardson-Vicks Inc.	Cosmetic sticks
US5274792A (en)	1989-08-19	1993-12-28	Fujitsu Limited	Information processing apparatus with parallel instruction decoding
SG47101A1 (en)	1992-07-31	1998-03-20	Us Bioscience	Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en)	1993-05-07	1994-09-20	American Cyanamid Company	2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en)	1993-05-07	1994-09-20	American Cyanamid Company	Diarylboron ester and thioester fungicidal agents
US5594151A (en)	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en)	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en)	1995-01-17	1995-03-08	Zeneca Ltd	Composition and use
GB9604926D0 (en)	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
WO1997048697A1 (en)	1996-06-19	1997-12-24	Rhone-Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en)	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en)	1996-09-19	1998-03-26	The Board Of Trustees Of Leland Stanford Jr. University	Dna adenine methyltransferases and uses thereof
EP0947498B1 (en)	1996-12-02	2004-09-15	Chisso Corporation	Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same
US6221640B1 (en)	1997-05-14	2001-04-24	Cubist Pharmaceuticals, Inc.	Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de)	1998-07-04	2000-01-05	Bayer Ag	Elektrolumineszierende Anordnungen mit Bor-Chelaten
TR200102277T2 (tr)	1998-11-06	2002-01-21	Basf Aktiengesellschaft Ag.	Üç halkalı (Trisiklik) pirazol türevleri
US6462036B1 (en)	1998-11-06	2002-10-08	Basf Aktiengesellschaft	Tricyclic pyrazole derivatives
EP1155698A4 (en)	1999-01-29	2003-01-15	Nitto Kasei Co Ltd	ORGANOBORAL COMPOUNDS HAVING COCCIDIOSTAT ACTIVITY
JP2003501431A (ja)	1999-05-25	2003-01-14	ザペンステートリサーチファウンデイション	Ｄｎａメチル基転移酵素阻害剤
DE60032614D1 (de)	1999-08-25	2007-02-08	Ambergen Inc	Verfahren zur erkennung, analyse und isolierung von freiwerdenden proteinen
US6306628B1 (en)	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
AU7995300A (en)	1999-10-05	2001-05-10	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
JP2003519187A (ja)	2000-01-06	2003-06-17	マランテックホールディングリミテッドライアビリティカンパニー	癌管理のための電子活性化合物の使用方法
US6521619B2 (en)	2000-06-29	2003-02-18	Icos Corporation	Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
WO2002006316A2 (en)	2000-07-14	2002-01-24	Zycos, Inc.	Alpha-msh related compounds and methods of use
EP1339725B1 (en)	2000-11-30	2006-11-22	The Penn State Research Foundation	Dna methyl transferase inhibitors
DE10110051C2 (de)	2001-03-02	2003-07-03	Clariant Gmbh	Verfahren zur Herstellung von Boron- und Borinsäuren
US7766013B2 (en)	2001-06-05	2010-08-03	Alexza Pharmaceuticals, Inc.	Aerosol generating method and device
EP1392262A1 (en)	2001-05-24	2004-03-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
GB0117645D0 (en)	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de)	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
WO2003033002A1 (en)	2001-10-11	2003-04-24	Ono Pharmaceutical Co	Intracellular calcium concentration increase inhibitors
WO2003059916A2 (en)	2002-01-10	2003-07-24	The Pennsylvania State Research Foundation	Methods for the preparation of alkyl diaryl borinates and complexed diarylborinic acids
IL166156A0 (en)	2002-07-09	2006-01-15	Point Therapeutics Inc	Boroproline compound combination therapy
US7446236B2 (en)	2002-12-02	2008-11-04	Solvias Ag	Catalytic hydrogenation of carbon-heteroatom double bonds
US7390806B2 (en)	2002-12-18	2008-06-24	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
EP1581500A4 (en)	2002-12-18	2008-03-05	Anacor Pharmaceuticals Inc	ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE
US20050125852A1 (en)	2003-05-09	2005-06-09	Sugen, Inc.	Novel kinases
US7465836B2 (en)	2003-06-16	2008-12-16	Anacor Pharmaceuticals, Inc.	Hydrolytically-resistant boron-containing therapeutics and methods of use
EP2335722B1 (en)	2004-05-12	2019-03-13	The Brigham and Women's Hospital, Inc.	Use of gelsolin to treat infections
AR049915A1 (es)	2004-06-14	2006-09-13	Anacor Pharmaceuticals Inc	Compuestos con contenido de boro y metodos de uso de los mismos
US20060111388A1 (en)	2004-11-19	2006-05-25	University Of North Texas Health Science Center At Fort Worth	Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en)	2005-01-31	2005-03-09	Univ Cambridge Tech	Compounds for use in chemical detection and/or quantitation
HUE026021T2 (en) *	2005-02-16	2016-05-30	Anacor Pharmaceuticals Inc	Biocidal boron phthalide (boronophthalide) compounds
US7919422B2 (en)	2005-03-08	2011-04-05	Agency For Science, Technology And Research	Chiral bisoxazoline catalysts
PE20061303A1 (es)	2005-03-30	2006-12-07	Astion Dev As	Composicion farmaceutica que comprende oxaprozina
US20080234229A1 (en)	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
CN106008583A (zh)	2005-12-30	2016-10-12	安纳考尔医药公司	含硼的小分子
BRPI0708051A2 (pt)	2006-02-16	2011-05-17	Anacor Pharmaceuticals Inc	moléculas pequenas contendo boro como agentes antiflamatórios
JP2009536660A (ja) *	2006-05-02	2009-10-15	アナコールファーマシューティカルズ，インコーポレイテッド	加水分解耐性ホウ素含有治療剤及びその使用方法
RU2008152367A (ru)	2006-06-12	2010-07-20	Анакор Фармасьютикалз, Инк. (Us)	Соединения для лечения периодонтального заболевания
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
KR100848491B1 (ko)	2007-01-16	2008-07-28	영진약품공업주식회사	베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) *	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
WO2009111676A2 (en)	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
KR101672511B1 (ko)	2008-03-06	2016-11-03	아나코르 파마슈티칼스 인코포레이티드	소염제로써 붕소가 함유된 소분자
WO2009140309A2 (en)	2008-05-12	2009-11-19	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
US8461336B2 (en)	2008-09-04	2013-06-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045505A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-protozoal agents
US9493489B2 (en)	2008-10-15	2016-11-15	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents
KR20110111407A (ko)	2008-12-17	2011-10-11	아나코르 파마슈티칼스 인코포레이티드	(ｓ)-３-아미노메틸-７-(３-히드록시-프로폭시)-３ｈ-벤조〔ｃ〕〔１,２〕옥사보롤-１-올의 다형태
WO2011017125A1 (en)	2009-07-28	2011-02-10	Anacor Pharmaceuticals, Inc.	Trisubstituted boron-containing molecules
HRP20211762T1 (hr) *	2010-09-07	2022-02-18	Anacor Pharmaceuticals, Inc.	Derivati benzoksaborola za liječenje bakterijskih infekcija

2011
- 2011-09-07 HR HRP20211762TT patent/HRP20211762T1/hr unknown
- 2011-09-07 LT LTEP17176654.6T patent/LT3251678T/lt unknown
- 2011-09-07 PL PL17176654T patent/PL3251678T3/pl unknown
- 2011-09-07 KR KR1020197003860A patent/KR102152901B1/ko active Active
- 2011-09-07 RS RS20211391A patent/RS62548B1/sr unknown
- 2011-09-07 CA CA2810021A patent/CA2810021C/en active Active
- 2011-09-07 KR KR1020137005717A patent/KR101949423B1/ko active Active
- 2011-09-07 AU AU2011299243A patent/AU2011299243C1/en active Active
- 2011-09-07 BR BR112013005426-3A patent/BR112013005426B1/pt active IP Right Grant
- 2011-09-07 CN CN2011800427618A patent/CN103140228A/zh active Pending
- 2011-09-07 MX MX2013002651A patent/MX338209B/es active IP Right Grant
- 2011-09-07 SI SI201132017T patent/SI3251678T1/sl unknown
- 2011-09-07 EA EA201390274A patent/EA028743B1/ru not_active IP Right Cessation
- 2011-09-07 CN CN201810051113.2A patent/CN108610356B/zh active Active
- 2011-09-07 US US13/227,444 patent/US8703742B2/en active Active
- 2011-09-07 JP JP2013527375A patent/JP5952280B2/ja active Active
- 2011-09-07 EP EP17176654.6A patent/EP3251678B1/en active Active
- 2011-09-07 SG SG2013014493A patent/SG187969A1/en unknown
- 2011-09-07 EP EP11758050.6A patent/EP2613788B1/en active Active
- 2011-09-07 DK DK11758050.6T patent/DK2613788T3/en active
- 2011-09-07 SG SG10201507032YA patent/SG10201507032YA/en unknown
- 2011-09-07 WO PCT/US2011/050728 patent/WO2012033858A2/en not_active Ceased
- 2011-09-07 DK DK17176654.6T patent/DK3251678T3/da active
- 2011-09-07 ES ES11758050.6T patent/ES2635333T3/es active Active
- 2011-09-07 ES ES17176654T patent/ES2898695T3/es active Active
- 2011-09-07 SM SM20210643T patent/SMT202100643T1/it unknown
- 2011-09-07 EA EA201791850A patent/EA033311B1/ru unknown
- 2011-09-07 PT PT171766546T patent/PT3251678T/pt unknown
- 2011-09-07 HU HUE17176654A patent/HUE059033T2/hu unknown
2013
- 2013-02-28 IL IL225000A patent/IL225000A/en active IP Right Grant
- 2013-03-01 ZA ZA2013/01598A patent/ZA201301598B/en unknown
2014
- 2014-03-21 US US14/221,637 patent/US9751898B2/en active Active
2016
- 2016-03-13 IL IL244556A patent/IL244556B/en active IP Right Grant
- 2016-06-09 JP JP2016114971A patent/JP2016199558A/ja not_active Withdrawn
2017
- 2017-08-24 US US15/685,846 patent/US20170355719A1/en not_active Abandoned
- 2017-10-06 JP JP2017195759A patent/JP6491294B2/ja active Active
2019
- 2019-02-28 JP JP2019035145A patent/JP2019112431A/ja active Pending
- 2019-07-30 US US16/526,248 patent/US11008345B2/en active Active
2021
- 2021-11-16 CY CY20211100990T patent/CY1124728T1/el unknown

Also Published As

Publication number	Publication date
WO2012033858A3 (en)	2012-05-10
ES2898695T3 (es)	2022-03-08
DK2613788T3 (en)	2017-08-07
PT3251678T (pt)	2021-11-22
US9751898B2 (en)	2017-09-05
KR20140093598A (ko)	2014-07-28
EA201791850A1 (ru)	2018-01-31
ES2635333T3 (es)	2017-10-03
MX2013002651A (es)	2013-04-19
CY1124728T1 (el)	2022-07-22
US11008345B2 (en)	2021-05-18
DK3251678T3 (da)	2021-11-22
CA2810021C (en)	2018-05-29
JP5952280B2 (ja)	2016-07-13
EP3251678A1 (en)	2017-12-06
LT3251678T (lt)	2021-12-10
HUE059033T2 (hu)	2022-10-28
SG187969A1 (en)	2013-04-30
CN103140228A (zh)	2013-06-05
EA033311B1 (ru)	2019-09-30
ZA201301598B (en)	2021-08-25
AU2011299243A1 (en)	2013-03-28
ES2898695T8 (es)	2022-03-16
RS62548B1 (sr)	2021-12-31
EP3251678B1 (en)	2021-10-20
CA2810021A1 (en)	2012-03-15
US20190345173A1 (en)	2019-11-14
CN108610356A (zh)	2018-10-02
IL244556A0 (en)	2016-04-21
EP2613788B1 (en)	2017-06-21
KR20190018549A (ko)	2019-02-22
SG10201507032YA (en)	2015-10-29
AU2011299243B2 (en)	2015-09-17
IL225000A (en)	2016-03-31
IL244556B (en)	2020-07-30
KR102152901B1 (ko)	2020-09-07
KR101949423B1 (ko)	2019-02-18
US20140315860A1 (en)	2014-10-23
CN108610356B (zh)	2021-02-26
JP2019112431A (ja)	2019-07-11
PL3251678T3 (pl)	2022-01-10
AU2011299243C1 (en)	2016-06-02
HK1247841A1 (en)	2018-10-05
US8703742B2 (en)	2014-04-22
JP2016199558A (ja)	2016-12-01
HRP20211762T1 (hr)	2022-02-18
JP6491294B2 (ja)	2019-03-27
WO2012033858A2 (en)	2012-03-15
MX338209B (es)	2016-04-07
US20170355719A1 (en)	2017-12-14
JP2018058836A (ja)	2018-04-12
EA201390274A1 (ru)	2013-08-30
EA028743B1 (ru)	2017-12-29
JP2013541514A (ja)	2013-11-14
EP2613788A2 (en)	2013-07-17
BR112013005426A2 (pt)	2016-06-07
US20120115813A1 (en)	2012-05-10
SI3251678T1 (sl)	2022-01-31
BR112013005426B1 (pt)	2021-08-24

Publication	Publication Date	Title
ZA201301598B (en)	2021-08-25	Benzoxaborole derivatives for treating bacterial infections
AP3269A (en)	2015-05-31	Methods and compounds for treating paramyxoviridaevirus infections
SG11201504813XA (en)	2015-07-30	Mannose derivatives for treating bacterial infections
ZA201303922B (en)	2014-07-30	Compounds useful for treating aids
PL2696890T3 (pl)	2021-12-27	Leczenie infekcji drobnoustrojowych
PT3616695T (pt)	2024-11-18	Ceftolozano/tazobactam para tratar infeções intrapulmonares
GB201212588D0 (en)	2012-08-29	Colicins for treating bacterial infections
EP2621497A4 (en)	2014-03-05	ASSOCIATION TREATMENT FOR ROSE ACNE
DK2473482T3 (en)	2014-05-12	Methods of treating orthomyxoviral infections
GB201019086D0 (en)	2010-12-29	Bacterial methods
EP2564835A4 (en)	2013-08-21	FAST DISSOLVING SOLID PHARMACEUTICAL FORM FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA201204249B (en)	2013-02-27	Treatment of microbial infections
EP2560679A4 (en)	2013-09-18	TREATMENT OF ECZEMA
ZA201302438B (en)	2021-05-26	Pharmaceutical composition for treating hcv infections
PH12012500528A1 (en)	2019-06-14	Compositions and methods for treating bacterial infections using caftaroline
ZA201308116B (en)	2014-12-23	Avian-based treatment for microbial infections
EP2529728A4 (en)	2013-07-17	PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
WO2011137376A9 (en)	2012-03-29	Compounds for anti-fungal treatment
EP2772248A4 (en)	2015-06-24	PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS
HK1179473A (en)	2013-10-04	Methods for treating infection
AU2011901619A0 (en)	2011-05-19	Avian-Based Treatment for Microbial Infection
EP2670407A4 (en)	2014-07-23	TREATMENT OF BACTERIAL INFECTIONS
AU2010901811A0 (en)	2010-05-13	Avian-Based Treatment for Microbial Infection
AU2010901718A0 (en)	2010-05-13	Eczema treatment
AU2011904604A0 (en)	2011-11-24	Gram positive bacterial infections treatment